PMID- 27882168 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1792-0981 (Print) IS - 1792-1015 (Electronic) IS - 1792-0981 (Linking) VI - 12 IP - 5 DP - 2016 Nov TI - Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review. PG - 3387-3389 AB - Infantile neuroaxonal dystrophy (INAD) is a rare neurodegenerative disease with early onset. PLA2G6 gene mutations have been identified in the majority individuals with INAD. In future, molecular diagnosis of INAD will replace the invasive biopsies used previously. In the present report, monozygotic male twins with INAD were referred The Children's Hospital (Zhejiang University School of Medicine, Zhejiang, China) at fifteen months old for delayed development. The older brother was found to have developmental stagnation when he was 6 months old. The patient could not stand securely without support, and had poor eye tracking and listening ability. Magnetic resonance imaging (MRI) of the patient's brain revealed cerebellar atrophy and electromyography identified signs of peripheral neuropathy. The younger brother displayed similar clinical features and findings. Two different phospholipase A2 group VI (PLA2G6; 22q13.1) gene mutations were detected in the twins by DNA sequencing. The results of the present study indicate that neurogenetic disease should be considered when child patients present with idiopathic developmental stagnation, particularly when similar cases have appeared in the same family. In addition, INAD should be considered as a possible diagnosis when the patient has developmental delay of the central and peripheral nerves. In the future, molecular genetic testing will be the primary method of INAD diagnosis, enabling better prevention of this genetic disease. FAU - Li, Haifeng AU - Li H AD - Rehabilitation Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310051, P.R. China. FAU - Zou, Yan AU - Zou Y AD - Nutrition and Food Safety Department, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, P.R. China. FAU - Bao, Xinhua AU - Bao X AD - Pediatric Department, Peking University First Hospital, Beijing 100034, P.R. China. FAU - Wang, Hui AU - Wang H AD - Rehabilitation Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310051, P.R. China. FAU - Wang, Jiangping AU - Wang J AD - Rehabilitation Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310051, P.R. China. FAU - Jin, Huiying AU - Jin H AD - Rehabilitation Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310051, P.R. China. FAU - Che, Yuping AU - Che Y AD - Rehabilitation Department, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310051, P.R. China. FAU - Tang, Xiaoyan AU - Tang X AD - Clinical Laboratory of Zhongke, Beijing 100034, P.R. China. LA - eng PT - Journal Article DEP - 20160930 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC5103811 OTO - NOTNLM OT - infantile neuroaxonal dystrophy OT - magnetic resonance imaging OT - phospholipase A2 group VI EDAT- 2016/11/25 06:00 MHDA- 2016/11/25 06:01 PMCR- 2016/09/30 CRDT- 2016/11/25 06:00 PHST- 2015/08/26 00:00 [received] PHST- 2016/08/11 00:00 [accepted] PHST- 2016/11/25 06:00 [entrez] PHST- 2016/11/25 06:00 [pubmed] PHST- 2016/11/25 06:01 [medline] PHST- 2016/09/30 00:00 [pmc-release] AID - ETM-0-0-3761 [pii] AID - 10.3892/etm.2016.3761 [doi] PST - ppublish SO - Exp Ther Med. 2016 Nov;12(5):3387-3389. doi: 10.3892/etm.2016.3761. Epub 2016 Sep 30.